by Keishi Foecke | May 7, 2025 | Blog Post
The U.S. life sciences industry is a key driver of economic growth and domestic manufacturing. American pharmaceutical manufacturers employ an estimated 291,000 employees, and for every one job in the pharmaceutical industry, four jobs are created in supporting...
by Keishi Foecke | May 1, 2025 | Blog Post
As the need for more effective and accessible obesity medicines grows, mergers and acquisitions (M&A) have emerged as a key strategy for life science companies of all sizes to accelerate innovation and competition to bring new treatment options to patients....
by Keishi Foecke | Apr 23, 2025 | Blog Post
Mergers and acquisitions (M&A) in America’s life sciences industry not only play a critical role in bringing new breakthroughs to patients, but also strengthen state economies across the country. Life sciences M&A plays a pivotal role in fueling innovation,...
by Keishi Foecke | Apr 16, 2025 | Blog Post
A new resource from the Partnership for the U.S. Life Science Ecosystem (PULSE) highlights the unique and fundamental role of mergers and acquisitions (M&A) in driving innovation across America’s biopharmaceutical industry. This new resource includes key insights...
by Keishi Foecke | Apr 3, 2025 | Blog Post
The American life sciences ecosystem operates in one of the most complex and high-risk investment environments. With more than 80% of life sciences companies operating without a profit, external investment—including from venture capital (VC)—is often critical to...
by Keishi Foecke | Mar 25, 2025 | Blog Post
For decades, mergers and acquisitions (M&A) have fueled the development and delivery of breakthrough treatments for complex diseases with a high unmet need. A new resource from the Partnership for the U.S. Life Science Ecosystem (PULSE) spotlights this unique and...
by Keishi Foecke | Mar 19, 2025 | Blog Post
New resources from the Partnership for the U.S. Life Science Ecosystem (PULSE) highlight the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. Life sciences M&A represents a critical pathway for companies of all...
by Keishi Foecke | Mar 12, 2025 | Blog Post, PULSE Partner
In a recent op-ed for The Maryland Daily Record, Kelly Schulz, CEO of PULSE Partner Maryland Tech Council, discusses how federal policy against mergers and acquisitions (M&A) could undermine Maryland’s status as an innovation leader in the life sciences....
by Keishi Foecke | Mar 5, 2025 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Keishi Foecke | Feb 26, 2025 | Blog Post
Competition policies that support pro-competitive mergers and acquisitions (M&A) are critical to fueling innovation, competition and growth in America’s life sciences industry. Importantly, M&A has a quantifiable impact for the ecosystem and for the thousands...
